Peer-Reviewed Publications

TAP was employed to collect capillary blood from 2-month-old infants for antibody tests of RSV and pertussis toxin.

Feasibility of home-based capillary sampling of colorectal cancer marker CEA was demonstrated. TAP was found to be “the most reliable method and is preferred by patients over venipuncture and lancet sampling.” (Erasmus MC)

TAP was employed to demonstrate the feasibility, high patient acceptance, and overall potential of a scalable axSpA hybrid telehealth care pathway.

TAP devices used to collect blood samples from 2-month-old and 12-month-old infants in Sars-CoV-2 infection risk study

TAP sample TSH and fT4 strongly correlate with venous blood using d-IA (digital immunoassay) method. These results may promote telemedicine in assessing thyroid function.

Transdermal capillary sampling using TAP is a sensitive, specific, and acceptable alternative to venous sampling for C-peptide testing in pediatric diabetes patients.

Correlation of capillary serum was demonstrated for professionally collected TAP II samples, self-collected TAP II samples, and professionally collected fingerstick samples.

TAP sampling can be used for assessing virus-specific cellular immunity.

TAP sample collection in decentralized drive-through settings enabled a comprehensive evaluation of Sars-CoV-2 antibody level and decay using WHO standards in a representative population of LA county during the pandemic.

TAP devices used to collect blood samples from 2-month-old and 6-month-old infants in Sars-CoV-2 infection risk study.

TAP devices successfully used to collect samples in siteless trial on covid antibody response study following booster shot. YourBio’s API platform enabled seamless integration.

TAP devices used to collect blood samples from 2-month-old and 6-month-old infants in Sars-CoV-2 infection risk study.

TAP device was validated for research use monitoring variation in human immune system within day and day-to-day.

Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.

Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.

Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.

Gateway SNAP, OEM device based on TAP design, was highly preferred over fingerstick by customers, with >99% accuracy for fetal gender sex determination.

TAP II used to collect samples for measurement of anti-SARS-CoV-2 antibodies in heart and lung transplant patients (n=134 HT, n=103 LT)

Remote sample collection with TAP device was first offered to transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.

Remote sample collection with TAP device was adopted by transplant patients as an alternative to traditional venous draw for measurement of anti-SARS-CoV-2 antibodies test.

TAP device enabled blood sample collections on athletes in the field for measurement of metabolites.

TAP device validated in conjunction with dried blood spot testing for panel of doping analytes.

TAP device was suitable for the measurement of IGF-1 in athlete samples.

The device was used to test for CK as an easy-to-measure, cost-effective marker that is able to assess muscle damage or trauma from high-intensity exercise.

TAP device was suitable for measuring Anti-Müllerian Hormone with the standard reference interval

TAP device may be a logistically-friendly source of blood for large scale metabolomics studies—especially those addressing amino acids, glycemia and lactatemia as well as bile acids, acyl-carnitine levels.

Point-of-care diagnostics necessitate simple, safe, and painless blood collection. We present a capillary blood-collection device with microneedles and a high-velocity mechanism, collecting 100 µl of blood with minimal pain. Clinically proven and FDA-cleared, it enhances healthcare accessibility and supports decentralization with easy, one-button operation.